NCT00407082View on ClinicalTrials.gov

Safety and Efficacy of Fluocinolone Acetonide Intravitreal Implants

PHASE2/PHASE3CompletedINTERVENTIONAL
Enrollment

278

Participants

Timeline

Start Date

December 31, 2000

Primary Completion Date

September 30, 2005

Study Completion Date

September 30, 2005

Conditions
Noninfectious Posterior Uveitis
Interventions
DRUG

fluocinolone acetonide intravitreal implant

Fluocinolone acetonide ocular implant 0.59mg

DRUG

Fluocinolone acetonide 2.1mg

Fluocinolone acetonide ocular implant 2.1mg

Trial Locations (1)

27710

Duke Eye Center, Durham

All Listed Sponsors
lead

Bausch & Lomb Incorporated

INDUSTRY

NCT00407082 - Safety and Efficacy of Fluocinolone Acetonide Intravitreal Implants | Biotech Hunter | Biotech Hunter